TECHNOLOGY:
COVID-19 detection using an ultra-fast breath test
AFFILIATION:
Callaghan Innovation and SYFT Technologies Ltd, Lower Hutt, Wellington, New Zealand
TECHNOLOGY SUMMARY
Area:
Diagnostic technologies for identification of SARS-CoV-2 from human nasal, buccal, or saliva samples
Tech Brief: Our Solution is the use of a breath test to detect COVID-19, the individual breathes into a device, the device gives instant readout as to the status of the person as regards COVID infection. Interfacing the known capability of COVID-19 detection by breath analysis using a commercially available breath device.
SHOWCASE SUMMARY
Org Type:
Academic/Gov Lab
FIGURES OF MERIT
Value Proposition: Our detection technology is unique, it has the potential to detect COVID-19 in real-time. No other technology outside of sniffer dogs can reliably detect COVID-19 in real-time. No technology can determine the molecular make-up of the COVID-19 breath biomarkers in real-time. Our technology is scalable by nature (unlike sniffer dogs). The technology has the prospect to detect asymptomatic patients which the current benchmark technology RT-PCR fails to achieve. The detection device can be placed anywhere, not relying on a complex infrastructure. The cost of a device is similar to the costs of a sniffer dog training program for COVID. The overall costs per test will be vastly smaller than current RT-PCR screening tests. Our technology has the potential to be automated directly with the individual taking the test. The test results being sent through to mobile tracer apps. Our technology does not rely on complex reagents for viral infection detection. Our technology does not rely on the taking of swab samples, their transport to a laboratory, trained skilled laboratory personnel etc. Our technology has the potential to deliver a result to a person in minutes (less than 5 minutes).